Rates of key safety events, such as malignancies and major adverse cardiovascular events, were comparable among patients receiving placebo and ustekinumab.
Related Keywords
New York , United States , Brucee Sands , Doximity Brucee Sands , Icahn School Of Medicine At Mount Sinai , Digestive Disease Week , Icahn School , Mount Sinai ,
comparemela.com © 2020. All Rights Reserved.